117 results
Page 4 of 6
SD
EX-1.01
hlrfzg jsy4
28 May 21
Conflict minerals disclosure
4:41pm
8-K
EX-99.1
vtk4ztm987r9gbr
10 May 21
Pulse Biosciences Reports First Quarter 2021 Financial Results
4:23pm
8-K
EX-10.1
ykebdfkyqvr139
11 Mar 21
Entry into a Material Definitive Agreement
4:32pm
8-K
EX-99.1
saxnq6yis6m7 ymy8
22 Feb 21
Pulse Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
4:18pm
424B5
clhn dap1e0nq
4 Feb 21
Prospectus supplement for primary offering
8:46am
8-K
EX-99.1
57u io0b797
4 Feb 21
Pulse Biosciences, Inc. Announces At-The-Market Equity Offering Program
8:30am
8-K
EX-1.1
73o5zgzj6e03
4 Feb 21
Pulse Biosciences, Inc. Announces At-The-Market Equity Offering Program
8:30am
8-K
EX-99.1
9dqyfml90
3 Feb 21
Pulse Biosciences Announces FDA Clearance for the CellFX® System
4:13pm
8-K
EX-99.1
ex0z2dox 8u3cck
25 Jan 21
Pulse Biosciences Announces CE Mark Approval for CellFX® System
8:12am
8-K
EX-99.1
hzmagun95ge920dzjog
5 Jan 21
Pulse Biosciences, Inc. Announces Redemption of Warrants
9:16am
8-K
EX-99.1
3pmoaafuyc6 62g
9 Nov 20
Pulse Biosciences Reports Third Quarter 2020 Financial Results
4:29pm
8-K
EX-99.1
43bzglyrjv1
10 Aug 20
Pulse Biosciences Reports Second Quarter 2020 Financial Results
4:27pm